Preoperative Serum Albumin and Duration of Intraoperative Hypotension on Postoperative Acute Kidney Injury
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03882658 |
|
Recruitment Status :
Completed
First Posted : March 20, 2019
Last Update Posted : May 7, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease |
|---|
| Acute Kidney Injury |
| Study Type : | Observational |
| Actual Enrollment : | 37610 participants |
| Observational Model: | Cohort |
| Time Perspective: | Retrospective |
| Official Title: | Preoperative Serum Albumin and Duration of Intraoperative Hypotension on Postoperative Acute Kidney Injury: a Retrospective Cohort Analysis |
| Actual Study Start Date : | January 10, 2018 |
| Actual Primary Completion Date : | January 20, 2019 |
| Actual Study Completion Date : | February 15, 2019 |
- incidence and odds ratio of postoperative acute kidney injury [ Time Frame: 30 days postoperatively in hospital ]incidence and odds ratio of postoperative acute kidney injury
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 100 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
adult non-cardiac, non-obsteric, non- kidney elective surgery patients
Exclusion Criteria:
patients aged <18 y emergency surgeries without arterial blood pressure cardiac surgeries obstetric surgeries kidney surgeries under local infiltration or MAC first SBP <100 mmHg
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03882658
| China, Beijing | |
| First hospital Peking University | |
| Beijing, Beijing, China, 100034 | |
| Principal Investigator: | Yan Zhou, MD, PhD | Peking University First Hospital |
| Responsible Party: | Yan Zhou, MD, Principal Investigator, Peking University First Hospital |
| ClinicalTrials.gov Identifier: | NCT03882658 |
| Other Study ID Numbers: |
ALBHYTAKI |
| First Posted: | March 20, 2019 Key Record Dates |
| Last Update Posted: | May 7, 2019 |
| Last Verified: | May 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Acute Kidney Injury Hypotension Wounds and Injuries Renal Insufficiency |
Kidney Diseases Urologic Diseases Vascular Diseases Cardiovascular Diseases |

